Home » Topics » BioWorld Science

BioWorld Science
RSS

Valeant Pharmaceuticals International to change name to Bausch Health Companies

May 8, 2018

FDA grants fast track designation to Debio-1347

May 8, 2018

Carna collaborates with Evotec to accelerate development of CB-1763

May 8, 2018

Polaris Pharmaceuticals creates new ADI-TRAIL fusion protein with antitumor activity

May 8, 2018

INTEREST study of Traumakine in ARDS does not meet primary efficacy composite endpoint

May 8, 2018

Takeda and Shire reach agreement on recommended offer for Shire

May 8, 2018

New trial explores use of AMO-01 in Phelan-McDermid syndrome

May 8, 2018

Aptose exercises option to license CrystalGenomics' CG-806

May 8, 2018

FDA approves Myrbetriq in combination with solifenacin for overactive bladder

May 8, 2018

QuANTUM-R study of quizartinib in FLT3-ITD-mutated AML meets primary endpoint

May 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...